Filing Flows › Globus Medical (GMED) › Q4 2025
Globus Medical (GMED) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Feb 24, 2026
Globus Medical (GMED) reported revenue of $826M for the fourth quarter 2025 (Q4 2025), +26% from a year earlier and +7% from the quarter before. Operating margin was 20.5%, net earnings $141M (17.0% of revenue).
Globus Medical, Q4 2025: revenue $826M (+26% year over year), operating margin 20.5%, net earnings $141M, operating cash flow $249M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $826M | +7% | +26% |
| Operating profit | $169M | +23% | +181% |
| Net earnings | $141M | +18% | +430% |
| Operating cash flow | $249M | -0.4% | +18% |
| Free cash flow | $202M | — | +5% |
What changed
Revenue was $826.4M in Q4 2025, up 26% year over year and up 7% from the previous quarter.
Operating profit was $169.3M, a 20.5% margin (up 11.3 points year over year). Of the extra revenue versus a year earlier, 64% reached operating profit, above the 9% margin then. Total costs grew 10% against revenue growth of 26%. The fastest-growing cost line was SG&A (+26%). Net earnings were $140.6M, up 430% year over year. The effective tax rate was 16.9%.
Operating cash flow was $248.6M (up 18% year over year), 177% of net earnings. Non-cash charges added back $69.0M of depreciation and amortization and $11.4M of share-based compensation. Working capital and other items added $27.6M. After purchases of property and equipment ($46.2M), free cash flow as the company reports it was $202.4M.
Questions
What was Globus Medical's revenue in the fourth quarter 2025?
Globus Medical (GMED) reported revenue of $826M for the fourth quarter 2025 (Q4 2025), +26% from a year earlier and +7% from the quarter before.
Was Globus Medical profitable in the fourth quarter 2025?
Operating profit was $169M (20.5% of revenue) and net earnings $141M.
Source: Globus Medical 10-K on SEC EDGAR.